Tag: astra

  • FDA lifts hold on AstraZeneca head and neck cancer trials

    LONDON (Reuters) – U.S. officials have given a green light for two clinical trials testing AstraZeneca's cancer immunotherapy drug durvalumab in head and neck cancer to resume recruiting patients, lifting a hold imposed following cases of bleeding. The British drugmaker said on Tuesday that one of the late-stage Phase III trials had already re-opened for…

  • FDA lifts hold on AstraZeneca head and neck cancer trials

    LONDON (Reuters) – U.S. officials have given a green light for two clinical trials testing AstraZeneca's cancer immunotherapy drug durvalumab in head and neck cancer to resume recruiting patients, lifting a hold imposed following cases of bleeding. The British drugmaker said on Tuesday that one of the late-stage Phase III trials had already re-opened for…

  • NHL-Highlights of Monday’s NHL games

    Highlights of Sunday’s National Hockey League games: Oilers 5, Blackhawks 0 After years of being tormented by their longtime nemesis from Chicago, the Edmonton Oilers gained a measure of revenge on Monday night with a 5-0 victory over the Blackhawks at Rogers Place Arena. Cam Talbot made 31 saves for the shutout as Edmonton beat…

  • NHL-Highlights of Monday’s NHL games

    Highlights of Sunday’s National Hockey League games: Oilers 5, Blackhawks 0 After years of being tormented by their longtime nemesis from Chicago, the Edmonton Oilers gained a measure of revenge on Monday night with a 5-0 victory over the Blackhawks at Rogers Place Arena. Cam Talbot made 31 saves for the shutout as Edmonton beat…

  • Mexico, Central America seek joint strategy on migrants as Trump looms

    By Sofia Menchu GUATEMALA CITY (Reuters) – The foreign ministers of Mexico, El Salvador, Honduras and Guatemala met on Monday to form a strategy to protect their migrants in the United States, in a show of regional solidarity following Donald Trump's win in the U.S. presidential election. Trump's election upset has sent shockwaves through Mexico…

  • Regulators, railroads target sleep apnea in wake of crash

    NEW YORK (AP) — Engineers suffering from sleep apnea must have the fatigue-inducing disorder under control before they will be allowed to operate trains for the New Jersey commuter railroad whose train slammed into a station in September, killing a woman and injuring more than 100 people.

  • Astrazeneca says Forxiga combination beats use of drug alone

    AstraZeneca said combining its Forxiga type-2 diabetes drug with older medicine Bydureon was more effective at controlling blood sugar levels than treatment with either drug on its own. In a late stage trial, Forxiga and Bydureon were tested on patients whose blood sugar levels could no longer be sufficiently kept in check under an initial…

  • Cost-cutting deal with unions key to VW’s recovery

    By Andreas Cremer BERLIN (Reuters) – Volkswagen's ability to agree a big cost-cutting plan with its powerful labor unions in the coming weeks could determine whether the German carmaker's shares make a full recovery from its emissions scandal. A year after it admitted using illegal software to rig diesel emissions tests, Volkswagen (VW) has still…

  • Novo plans larger study after encouraging semaglutide results

    By Nikolaj Skydsgaard COPENHAGEN (Reuters) – Novo Nordisk's experimental injectable diabetes drug semaglutide reduced cardiovascular risk by 26 percent, according to results released on Friday, paving the way for a new and bigger study on the drug's benefits. Semaglutide is the third diabetes drug to show such heart benefits, after Novo's Victoza injectable and Eli…

  • AstraZeneca taps gene pioneer Venter for huge drug-hunting sweep

    By Ben Hirschler CAMBRIDGE, England (Reuters) – AstraZeneca, working with genome pioneer Craig Venter, is launching a massive gene hunt in the most comprehensive bet yet by a pharmaceutical firm on the potential of genetic variations to unlock routes to new medicines. The initiative, announced on Friday, involves sequencing up to 2 million human genomes…